x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

Global Regions ( XML Feed )
United States ( XML Feed )

Aug 21, 2015 1:25 EST

BioViva USA, Inc.: creating regenerative medicine to alleviate diseases caused by cellular degeneration and genetic disorders

iCrowdNewswire - Aug 21, 2015

BioViva USA, Inc.

BioViva USA, Inc. Logo

 

Gene therapy company that treats diseases and aging at the cellular level… with a potential solution to Alzheimer’s Disease and Atherosclerosis. Human clinical trials are scheduled.

We are committed to creating regenerative medicine to alleviate diseases caused by cellular degeneration and genetic disorders. We focus on aging, as this is the common root of most major diseases.

We bring these treatments to the clinic for both compassionate and consensual use and to change how we treat disease in the future.

Products / Services

Gene therapies for major aging-related disease and conditions

BioViva offers potential single treatment cures and vaccines for Alzheimer’s Disease, atherosclerosis and sarcopenia and will begin human clinical trials in 2015.

Gene therapy

Aging is a complex process that inevitably leads to disease and dysfunction and this is why we are targeting our therapies to treat it to head disease off at the pass. These are some of our immediate targets to develop gene therapies for, and this will develop as we develop new ways to treat illness and learn more about aging:

* Lengthen Telomeres
* Reverse Atherosclerosis
* Clear Misfolded Proteins
* Clear Senescent Cells
* Re-strengthen Muscles
* Re-boot the immune System
* Improve Cell Signaling
* Treat Monogenic Disease

Contact Information:

David Kekich

View Related News >
support